Full-Time

Senior Clinical Data Manager

Posted on 5/12/2026

Fortrea

Fortrea

10,001+ employees

Global CRO managing phase I–IV trials

No salary listed

Bengaluru, Karnataka, India

Hybrid

Potential travel up to 10% with overnight stays.

Category
Biology & Biotech (1)
Required Skills
biometrics
SAS
Google Cloud Platform
Requirements
  • University / college degree.
  • Experience and/or education plus relevant work experience, equating to a bachelor's degree will be accepted in lieu of a bachelor’s degree.
  • Fortrea may consider relevant and equivalent experience in lieu of educational requirements.
  • Language Skills Required: Speaking/Writing/Reading: English required.
  • Eight years of combined early or late-stage Data Management experience with minimum two years of direct sponsor management and at least two years of technical mentoring experience.
  • Proven experience in handling customer negotiations and managing Scope of Work and budgets.
  • Thorough knowledge of clinical trial process, Data Management, clinical operations, biometrics, and system applications to support operations.
  • Time management skills and ability to adhere to project productivity metrics and timelines.
  • Ability to mentor junior members of the department, providing SME guidance on Data Management practices.
  • Experience of representing Data Management in bid defense meetings, providing innovative solutions to meet client needs.
  • Good organizational ability, communication, and interpersonal skills.
  • Constructive problem-solving attitude while deadline-focused with time demands, incomplete information or unexpected events.
Responsibilities
  • Lead studies including (but not limited to) a combination of healthy volunteer and patient populations, multi-site, complex protocol design, strong client management required or reduced timelines.
  • As the Study Manager, be accountable for all Data Management deliverables as assigned per the established timeline; providing instruction to their Data Management study team(s) and review of their study team’s output to ensure the highest quality, while adjusting resource allocations accordingly.
  • Ensure that all allocated projects are carried out in strict accordance with the relevant protocols, global harmonized Standard Operating Procedures, and the specified standards of Good Clinical Practice.
  • Work with the Project Manager(s) or Fully-Serviced Project Lead (or designee) to build timelines to meet contracted milestones by communicating with leads in different disciplines and the full project team as necessary, including at study initiation meetings.
  • Provide DM project team leadership and accountability; leads data focused internal project team meetings; meets frequently with the study leads of Electronic Data Capture Design, Statistical Analysis System Programming, Statistics, and Pharmacokinetics to ensure that all deliverables are planned and coordinated intradepartmental; proactively identifies potential risks/mitigations, effectively communicates data-driven discussions in order to achieve database lock dates; keeps the Project Manager or Fully-Serviced Project Lead (or designee) apprised of project progress.
  • Maintain awareness of other Biometrics functional group deliverables to be able to support risk and mitigation strategies, including impact on DM resources or deliverables and consult with Project Manager (or designee) and/or functional group management as necessary.
  • Keep Project Manager (or designee), Biometrics management team and/or sponsor services informed of pertinent project or sponsor related information (i.e., budget status, work scope changes, timeline impacts).
  • Coordinates the receipt and inventory of all data related information, from clinical sites and vendors as appropriate to meet timelines for deliverables.
  • Develop and maintain client relationships and review client satisfaction surveys. Implement appropriate action plans including driving process improvements and team training.
  • Track scope changes and work with the Project Manager or Fully-Serviced Project Lead (or designee) to ensure that Sponsor approval is received, and the scope change processed.
  • Provides leadership, mentorship, and coaching in DM related clinical trial processes, department technical capabilities, and associated turnaround durations to the internal study team.
  • Provide support to DM supervisors and managers on the performance evaluation of other team members, provide constructive feedback to aid in career development, interpersonal skills, and achievement of competency standards.
  • Accountable for learning new DM technologies and applied processes, keeping up to date with industry wide technology and feasibility for process improvement at Fortrea.
  • Ensures service and quality meet agreed upon specifications per the Data Management Plan and scope of work.
  • Have input in writing, reviewing, and updating Standard Operating Procedures and associated documents as required.
  • Maintain accurate records of all work undertaken.
  • Perform reconciliation of the clinical database against safety data, laboratory data or any other third-party data as appropriate. Utilize local laboratory systems and batch data load facilities where appropriate.
  • Represent DM and where necessary overall Biometrics in new business opportunities.
  • Attend and action client or internal audits as appropriate and resolve all issues within an appropriate timeframe. Address client comments with the study team.
  • Works with management team to develop and implement directional strategy by providing technical input into discussions and rolling out training/mentorship to DM staff (as required).
  • Actively promote Biometrics services to sponsors whenever possible.
  • Performs other related duties as assigned by management.
  • All other duties as needed or assigned.
Desired Qualifications
  • University / college degree (life sciences, health sciences, information technology or related subjects preferred).
  • Through knowledge of Fortrea, the overall structure of the organization and Standard Operating Procedures (SOPs).
  • Four or more years of Electronic Data Capture experience.

Fortrea is a global contract research organization (CRO) that provides clinical trial management, clinical pharmacology services, and consulting for pharmaceutical, biotechnology, and medical device companies. It runs Phase I–IV trials, operates its own clinical trial sites, and handles patient recruitment including healthy volunteers and patients with specific conditions. It offers mobile clinical solutions to improve patient retention and adherence and tailors its services to each client’s needs, generating revenue from fees for research and development services. Fortrea aims to streamline the clinical trial process and support innovation in its clients' trials by delivering customized, end-to-end trial delivery solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Durham, North Carolina

Founded

2023

Simplify Jobs

Simplify's Take

What believers are saying

  • FIT platform expansion across clinical pharmacology, development, and medical devices drives revenue.
  • Strong biotech activity and three consecutive quarters above 1.1x book-to-bill sustains growth.
  • Over $0.5 billion liquidity enables strategic investments and debt reduction initiatives.

What critics are saying

  • IQVIA's superior AI platform erodes Fortrea's biotech bookings within 12-18 months.
  • Customer concentration exposes Fortrea to 15-20% revenue loss from single contract.
  • PPD and ICON undercut Fortrea's functional services pricing, compressing margins significantly.

What makes Fortrea unique

  • Fortrea Intelligent Technology suite automates clinical trial workflows with AI-powered analytics.
  • Book-to-bill ratio of 1.15x in Q1 2026 signals strong biotech demand momentum.
  • Adjusted EBITDA surged 55% year-over-year to $47 million through operational efficiency.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Fortrea who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Paid Vacation

Company News

Connectweb Technologies, Inc.
Apr 7th, 2026
Fortrea unveils Fortrea Intelligent Technology(TM) to help sponsors and sites run Smarter, more integrated trials.

Fortrea unveils Fortrea Intelligent Technology(TM) to help sponsors and sites run Smarter, more integrated trials. Fortrea Holdings Inc AI-enhanced suite of solutions features new and improved technology to empower efficiency, confidence and quality. Highlights: * Designed to transform clinical trial operations for sponsors, sites and study teams * Persona driven, AI-powered solutions automate workflows and streamline oversight to help improve trial speed, predictability and quality * Builds on Fortrea's flagship platform Xcellerate(R) to deliver near-real-time, role-based insights DURHAM, N.C., April 07, 2026 (GLOBE NEWSWIRE) - Fortrea (Nasdaq: FTRE), a leading global clinical research organization (CRO), today unveiled Fortrea Intelligent Technology(TM)(FIT), a suite of innovative technology solutions designed to transform clinical trial operations. By integrating persona-driven, AI-powered solutions that automate workflows, streamline oversight and elevate productivity, FIT helps enable sponsors, investigator sites and Fortrea project teams to deliver trials faster, with greater predictability, agility and quality. An Innovative, Intelligent Suite of Clinical Solutions FIT encompasses major enhancements to familiar Fortrea offerings, including the award-winning Xcellerate(R) platform, along with newly launched solutions designed to integrate all processes within the trial ecosystem. The suite boasts applications for biopharma and biotech customers across clinical pharmacology, clinical development and medical device development, and it can be deployed in both full service and functional service models, with select components available as software-as-a service (SaaS). FIT solutions are arranged into three pillars: * Lifecycle: Deliver Trials Faster with Confidence Solutions that help sponsors and sites progress clinical trials throughout each step of the clinical development journey. They help accelerate clinical trials by automating key steps, from pre-award to final eTMF. * Foresight: Turn Data into Actionable Insights Solutions that transform data into foresight, helping enable faster decision-making and proactive risk mitigation. They provide clarity, trend analysis and risk mitigation through intuitive dashboards that empower confident, near-real-time decisions and simplified oversight. * Companion: Empowering Study Teams to Work Smarter Persona-driven, AI-powered solutions that support more productive and efficient clinical trial operations. They help streamline study delivery, help boost productivity and enable collaboration. "We are at a remarkable moment in time, where the evolution of clinical trials is converging with unprecedented advancements in technology. Fortrea Intelligent Technology sits at this nexus," said Chief Information Officer Alejandro Martinez Galindo. "Built on decades of industry experience and direct sponsor and investigator site input, FIT delivers human-centered solutions that enable sponsors and sites to conduct trials more efficiently, with greater confidence and lower risk." Xcellerate(R) Anchors the Intelligent Suite Xcellerate(R), Fortrea's platform for Risk-Based Quality Management (RBQM), Central Monitoring and Oversight, is the foundation of the FIT offering. Recent enhancements deliver a modern, intuitive experience that integrates data across the trial ecosystem to provide near-real-time, role-based insights. With embedded AI and machine learning, Xcellerate(R) can analyze complex patterns, generate predictive signals and initiate automated workflows, reducing manual effort and enabling teams to focus on the critical human judgment required for successful clinical research. "We expect these Xcellerate(R) enhancements and the broader FIT platform will be game changers for our study teams and our clients," said Chief Operating Officer and President, Clinical Development Mark Morais. "Incorporating the responsible and ethical use of AI, these technologies enable a stronger research ecosystem and the ability to respond more quickly to what the data are telling us - all of which can make the difference in getting life-changing treatments to patients faster and more efficiently." Fortrea continues to expand the Fortrea Intelligent Technology portfolio, with additional solutions planned for future release. About Fortrea Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. Connectweb partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Its talented and diverse team, operating across approximately 100 countries, is scaled to deliver focused, agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow Connectweb on LinkedIn, X and Bluesky. Fortrea Contacts: Jennifer Minx (Media) - 919-410-4195, [email protected] Kate Dillon (Media) - 646-818-9115, [email protected] Tracy Krumme (Investors) - 984-385-6707, [email protected]

Yahoo Finance
Apr 7th, 2026
Fortrea launches AI-powered technology suite to speed up clinical trials

Fortrea, a global clinical research organisation, has unveiled Fortrea Intelligent Technology (FIT), an AI-enhanced suite of solutions designed to transform clinical trial operations for sponsors, sites and study teams. The platform builds on Fortrea's Xcellerate system to deliver persona-driven, AI-powered solutions that automate workflows and streamline oversight. FIT is organised into three pillars: Lifecycle, which accelerates trials from pre-award to final eTMF; Foresight, providing near-real-time insights and risk mitigation through intuitive dashboards; and Companion, offering AI-powered tools to boost productivity and collaboration. The suite is available for clinical pharmacology, clinical development and medical device development, deployable in full service and functional service models, with select components available as software-as-a-service.

Yahoo Finance
Feb 26th, 2026
Fortrea reports $2.7B revenue, $190M EBITDA as book-to-bill hits 1.14x

Fortrea reported Q4 revenue of $660.5 million, down 5.2% year-over-year, and full-year revenue of $2.723 billion, up 1% and within guidance. Q4 adjusted EBITDA was $54 million, whilst full-year adjusted EBITDA reached $189.9 million. The company posted a Q4 GAAP net loss of $32.5 million. Management noted improving demand, with Q4 book-to-bill at 1.14x and backlog at $7.7 billion, driven by higher client engagement and increased biotech RFP flow. Fortrea exceeded cost-savings targets, delivering $153 million gross savings, and generated strong Q4 operating cash flow of $129.1 million. The company repurchased $75.7 million of senior notes and ended with over $600 million liquidity. For 2026, Fortrea guided revenue of $2.55–2.65 billion with adjusted EBITDA of $190–220 million.

Yahoo Finance
Feb 25th, 2026
Fortrea reports Q4 results tomorrow with revenue expected to decline 4.3% year on year

Clinical research company Fortrea Holdings reports Q4 earnings tomorrow. Analysts expect revenues to decline 4.3% year on year, following a 1.8% decrease in the same quarter last year. Last quarter, Fortrea beat revenue expectations with $701.3 million, up 3.9% year on year, and issued full-year guidance exceeding analysts' forecasts. However, the company has missed Wall Street's revenue estimates multiple times over the past two years. Analysts have largely maintained their estimates over the last 30 days. Shares have declined 36.8% over the past month, underperforming the drug development inputs and services segment, which averaged a 1.1% decline. The stock currently trades at $10.98 against an average analyst price target of $16.44.

The Associated Press
Feb 17th, 2026
Fortrea appoints Oren Cohen as chief medical officer and Scott Dove as president of Clinical Pharmacology Services

Fortrea, a global contract research organisation, has expanded its executive team with two appointments. Oren Cohen, who previously served as both chief medical officer and president of Clinical Pharmacology Services, will now focus solely on his CMO responsibilities, overseeing medical strategy, scientific leadership and governance across Fortrea's portfolio. Scott Dove has joined as president of Clinical Pharmacology Services, responsible for early clinical development solutions across Fortrea's global network. Dove brings over 25 years of drug development experience, most recently serving as chief operating officer at Aravive and holding leadership roles at PPD, Allergan and Furiex Pharmaceuticals. Both Cohen and Dove serve on Fortrea's Executive Committee. The company provides clinical trial management and consulting services across more than 20 therapeutic areas.